CERE
Cerevel Therapeutics Holdings, Inc.
CEO and Chair N Anthony Coles sold $1.6M of Cerevel Therapeutics Holdings, Inc.
Sold$1,630,070
$32.60Price
50,000Shares
−95%Stake
What CERE did after the filing
- The stock from Tue, Jun 6 open, $32.73
- −10.7%
- S&P 500, same days
- +6.4%
Measured over 30 trading days, to the Jul 20 close.
Traded Thu, Jun 1. Filed Mon, Jun 5, 4:12 PM ET, after the close. Returns use the Jun 6 open and the Jul 20 close. Not investment advice.